Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Balance of Effector and Regulatory Cell Populations in Oral Chronic GVHD: Potential Role of IL-15.

Matin Imanguli, DDS, Frances Hakim, PhD, William Swaim, PhD, Jean-Pierre Guadagnini, DDS, Stacy League, BA, Ronald Gress, MD, Steven Pavletic, MD

Blood (2007) 110 (11): 1059.

https://doi.org/10.1182/blood.V110.11.1059.1059

Published: 2007

Journal Articles

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Nancy M. Hardy, MD, Frances Hakim, PhD, Seth Steinberg, PhD, Michael Krumlauf, Rebecca Babb, Jeanne Odom, Daniel Fowler, MD, Ronald Gress, MD, Michael R. Bishop, MD

Blood (2006) 108 (11): 2871.

https://doi.org/10.1182/blood.V108.11.2871.2871

Published: 2006

Journal Articles

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

Robert M. Dean, MD, Daniel Fowler, MD, Wyndham H. Wilson, MD, PhD, Frances Hakim, PhD, Seth Steinberg, PhD, Jeanne Odom, RN, Catherine Chow, MD, Claude Sportes, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD, Nancy M. Hardy, MD, Ronald Gress, MD, Michael R. Bishop

Blood (2006) 108 (11): 317.

https://doi.org/10.1182/blood.V108.11.317.317

Published: 2006

Journal Articles

Early Recovery of Thymus-Derived Naïve T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.

Terry J. Fry, MD, Alison R. Rager, Frances Hakim, PhD, Cynthia Love, Paula Layton, Daniel Fowler, MD, Michael R. Bishop, MD, Ronald Gress, MD, Crystal L. Mackall, MD, Alan S. Wayne, MD

Blood (2006) 108 (11): 310.

https://doi.org/10.1182/blood.V108.11.310.310

Published: 2006

Journal Articles

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Claude Sportes, MD, Michael Krumlauf, RN, Rebecca Babb, RN, Ladan Foruraghi, RN, Janine Daub, RN, Daniele Avila, RN, Catherine Chow, MD, Hua Zhang, PhD, Kevin Chua, PhD, Terry Fry, MD, Sarfraz Memon, PhD, Frances Hakim, PhD, Thomas Fleisher, MD, Margaret Brown, BSN, Julie Engel, PhD, Renaud Buffet, MD, Michel Morre, DVM, Ronald Gress, MD, Crystal Mackall, MD

Blood (2006) 108 (11): 871.

https://doi.org/10.1182/blood.V108.11.871.871

Published: 2006

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric Patients with Malignancy.

Terry J. Fry, MD, Teresa Cardesa-Salzman, MD, Frances Hakim, PhD, Cynthia Love, R.N., BSN., Paula Layton, R.N., BSN, Ronald Gress, MD, Daniel Fowler, MD, Michael R. Bishop, MD, Crystal L. Mackall, MD, Alan S. Wayne, MD

Blood (2005) 106 (11): 3672.

https://doi.org/10.1182/blood.V106.11.3672.3672

Published: 2005

Journal Articles

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Nancy M. Hardy, MD, Vicki Fellowes, Jacopo Mariotti, MD, Charles Carter, Carl June4, MD, Bruce L. Levine4, PhD, Frances Hakim, PhD, Robert Vonderheide4, MD, DPhil, Ronald Gress, MD, Elizabeth J. Read, MD, Daniel Fowler, MD, Michael R. Bishop, MD

Blood (2005) 106 (11): 5407.

https://doi.org/10.1182/blood.V106.11.5407.5407

Published: 2005

NARROW

The Balance of Effector and Regulatory Cell Populations in Oral Chronic GVHD: Potential Role of IL-15.

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

Early Recovery of Thymus-Derived Naïve T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric Patients with Malignancy.

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

The Balance of Effector and Regulatory Cell Populations in Oral Chronic GVHD: Potential Role of IL-15.

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

Early Recovery of Thymus-Derived Naïve T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric Patients with Malignancy.

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only